دورية أكاديمية
The Nairobi Declaration 2023: A commitment to address deadly yet neglected fungal diseases in Africa.
| العنوان: | The Nairobi Declaration 2023: A commitment to address deadly yet neglected fungal diseases in Africa. |
|---|---|
| المؤلفون: | Osaigbovo II; Department of Medical Microbiology, School of Medicine, College of Medical Sciences, University of Benin, Benin City, Nigeria., Govender NP; National Institute for Communicable Diseases, a Division of the National Health Laboratory Service, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa., Jordan AM; Mycotic Diseases Branch, Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, United States of America., Bongomin F; Department of Medical Microbiology and Immunology, Faculty of Medicine, Gulu University, Gulu, Uganda., Meya DB; Infectious Diseases Institute, Makerere University, Kampala, Uganda., Kanyua A; Department of Pathology and Laboratory Medicine, Aga Khan University, Nairobi, Kenya., Mashedi OM; Kenya Medical Research Institute, Nairobi, Kenya., Koffi D; Institut Pasteur de Côte d'Ivoire, Abidjan, Cote d'Ivoire., Loyse A; Division of Infection and Immunity Research Institute, St George's University of London, London, United Kingdom., Sturny-Leclère A; Institut Pasteur, Universite Paris Cite, National Reference Center for Invasive Mycoses and Antifungals, Translational Mycology research group, Mycology Department, F-75015, Paris, France., Gangneux JP; CHU de Rennes, University of Rennes, INSERM, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Rennes, France., Denning DW; Manchester Fungal Infection Group, Division of Evolution, Infection and Genomics, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, United Kingdom., Chiller T; Mycotic Diseases Branch, Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, United States of America., Cornely OA; Department of Internal Medicine, European Diamond Excellence Center of Medical Mycology, University Hospital Cologne, Cologne, Germany., Oladele RO; Department of Medical Microbiology and Parasitology, Faculty of Basic Medical Sciences, College of Medicine, University of Lagos, Lagos, Nigeria. |
| المصدر: | Medical mycology [Med Mycol] 2024 Jan 09; Vol. 62 (1). |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9815835 Publication Model: Print Cited Medium: Internet ISSN: 1460-2709 (Electronic) Linking ISSN: 13693786 NLM ISO Abbreviation: Med Mycol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2014- : Oxford : Oxford University Press Original Publication: Oxford : Blackwell Science, c1998- |
| مواضيع طبية MeSH: | Mycoses*/diagnosis , Mycoses*/drug therapy , Mycoses*/epidemiology , Mycoses*/veterinary , Mucormycosis*/drug therapy , Mucormycosis*/veterinary , Invasive Fungal Infections*/diagnosis , Invasive Fungal Infections*/veterinary, Humans ; Kenya/epidemiology ; Antifungal Agents/therapeutic use |
| مستخلص: | On May 30th and 31st, 2023, delegates representing various African subregions, together with global representatives from the International Society of Human and Animal Mycology (ISHAM), the European Confederation of Medical Mycology (ECMM), the United States Centre for Disease Control and Prevention (CDC), and Global Action for Fungal Infections (GAFFI), convened in Nairobi, Kenya under the aegis of the Pan African Mycology Working Group, a working group of ISHAM. The meeting objectives were, amongst others, to deliberate on a continental response to the World Health Organisation Fungal Priority Pathogen List and facilitate interaction between global and regional leaders. Country delegates and international speakers addressed Africa's fungal disease burden; capacity for diagnosis and management; ongoing surveillance; knowledge gaps and trends in invasive fungal diseases such as Candida auris, mucormycosis, aspergillosis, and Acquired Immune Deficiency Syndrome (AIDS)-related mycoses; and current laboratory practice. During the technical sessions, expert panels deliberated on establishing and financing of national/regional surveillance networks for mycoses; establishing and sustaining African-led collaborations; expanding on existing laboratory and point-of-care diagnostic capacity as well as planning a mycology reference laboratory service and network in Africa. The meeting also highlighted successful African-led collaborations, capacity building, and clinical trial initiatives. The meeting conclusions informed the resolutions of the Nairobi Declaration calling for improved awareness; strong collaborations between clinical and laboratory teams across Africa; improved fungal disease surveillance within the continent; access to antifungals and diagnostics; and leveraging qualified human resources for mycology present within and outside Africa to facilitate trainings, collaborations, and exchanges. (© The Author(s) 2023. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.) |
| فهرسة مساهمة: | Keywords: Aspergillus; Candida; Africa; antifungal; laboratory Local Abstract: [plain-language-summary] This review presents the current state of the art in medical mycology in Africa discussed at the first scientific meeting of the Pan African Mycology Working Group, an affiliate of the International Society for Human and Animal Mycology (ISHAM) held in Nairobi, Kenya on May 30th and 31st, 2023. |
| المشرفين على المادة: | 0 (Antifungal Agents) |
| تواريخ الأحداث: | Date Created: 20231228 Date Completed: 20240116 Latest Revision: 20240117 |
| رمز التحديث: | 20240118 |
| DOI: | 10.1093/mmy/myad141 |
| PMID: | 38154488 |
| قاعدة البيانات: | MEDLINE |
PDF full text from Publisher | تدمد: | 1460-2709 |
|---|---|
| DOI: | 10.1093/mmy/myad141 |